Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Mitra Pinasthika Mustika Tbk. (MPMX) Price & Performance

UBC Medical Indonesia Tbk.Trade
Mitra Pinasthika Mustika Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Mitra Pinasthika Mustika Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Mitra Pinasthika Mustika Tbk. trades at Rp1,030 (market cap 4.54T, 5.97M 24h volume). The key difference: Mitra Pinasthika Mustika Tbk. is far larger — about 6.6× UBC Medical Indonesia Tbk.'s market cap, and Mitra Pinasthika Mustika Tbk. is more actively traded (5.97M versus 635.5K). Which is the better fit depends on your goals.

LABSMPMX
Market Cap
691.25B4.54T
Volume
635.5K5.97M
Lot
6.36K59.74K
Turnover
110.15M6.12B
Average Price
173.331,024.07
Value
110.15M6.12B
Indicative Equilibrium Price
1741,030
Indicative Equilibrium Volume
50178

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MPMX
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Mitra Pinasthika Mustika Tbk.

PT Mitra Pinasthika Mustika Tbk (the Company) was establised by deed of notary public Mrs. Rukmasanti Hardjasatya, S.H., Jakarta No. 2 dated November 2, 1987 and amended with deed No.6 dated 1 July 1988.

Read more on MPMX